rediff.com
HOME   |   MY UPDATES
X 
Already a User? Sign in!
Your email ID
 
Password
Keep me signed in (Uncheck if on shared computer)
 
 
Forgot password?
New user?   Sign up
X 
Verify your account

You're almost done! We just need to verify your account before you can
start using it.

Your Mobile No.
+91 
 
Enter the code you received on sms >
Resend Code (Incase you don't get sms from us).
 

Note: Rediff will never share your number with any company for marketing purpose.

X 
We have sent you an email to . Please click on the link in the email to confirm your emailID.

Dishman-Pharmaceuticals-Chemicals-Ltd

400 characters

  Loading ! Please wait...
Step 1 of 4 : Album created
Hot Topics
Women-Smarter-Than-Men?

#Women-Smarter-Than-Men?

UnFollow
Follow
Best-City-To-Live-In

#Best-City-To-Live-In

UnFollow
Follow
Does-TV-Promote-Crime?

#Does-TV-Promote-Crime?

UnFollow
Follow
36 posts so far
Refresh

Rediff

reports Q4 numbers with PAT at Rs 18.6 crore vs Rs 31 crore, (YoY). (ET Now)
#Earnings
#money

#Dishman-Pharmaceuticals-Chemicals-Ltd reports Q4 numbers with PAT at Rs 18.6 crore vs Rs 31 crore, (YoY). (ET Now) #Earnings #money
3 weeks ago 
Sab ko Bol
  - Reply
 - Share

mukesh dishman slowly going to achieve intraday target of 73

#money

dishman slowly going to achieve intraday target of 73 #Dishman-Pharmaceuticals-Chemicals-Ltd #money
1 week ago 
Sab ko Bol
  - Reply
 - Share

mukesh buy it for intraday target of 73

#money

buy it for intraday target of 73 #Dishman-Pharmaceuticals-Chemicals-Ltd #money
1 week ago 
Sab ko Bol
  - Reply
 - Share

Marina Boseyes :-*

 
yes :-*
1 week ago  
Sab ko Bol
  - Reply

mukesh buy Dishman pharma at current level as Q4 earnings of company very strong for futurekeep sl of 69 tgt. 88

#money

buy Dishman pharma at current level as Q4 earnings of company very strong for futurekeep sl of 69 tgt. 88 #Dishman-Pharmaceuticals-Chemicals-Ltd #money
1 week ago 
Sab ko Bol
  - Reply
 - Share

Vinod Kashyap BUY

#money

BUY #Dishman-Pharmaceuticals-Chemicals-Ltd #money
1 week ago 
Sab ko Bol
  - Reply
 - Share

Rediff

reports Q4 numbers with sales at Rs 345 crore vs Rs 350 crore, (YoY). (ET Now)
#Earnings
#money

#Dishman-Pharmaceuticals-Chemicals-Ltd reports Q4 numbers with sales at Rs 345 crore vs Rs 350 crore, (YoY). (ET Now) #Earnings #money
3 weeks ago 
Sab ko Bol
  - Reply
 - Share

sunil kumar sell sell short term taregt 62

#money

sell sell short term taregt 62 #Dishman-Pharmaceuticals-Chemicals-Ltd #money
3 weeks ago 
Sab ko Bol
  - Reply
 - Share

ATAULLAH KHAN insaallah buy dishman strong fundamental with a target of 88

#money

insaallah buy dishman strong fundamental with a target of 88 #Dishman-Pharmaceuticals-Chemicals-Ltd #money
3 months ago 
Sab ko Bol
  - Reply
 - Share

Rediff

: We are in the process of altering forex strategy to curb losses. (ET Now)
#money

#Dishman-Pharmaceuticals-Chemicals-Ltd: We are in the process of altering forex strategy to curb losses. (ET Now) #money
4 months ago 
Sab ko Bol
  - Reply
 - Share
1 more updates from Rediff »

Rediff

reports Q3 numbers with sales at Rs 318 crore vs 265 crore, (YoY). (ET Now)
#Earnings
#money

#Dishman-Pharmaceuticals-Chemicals-Ltd reports Q3 numbers with sales at Rs 318 crore vs 265 crore, (YoY). (ET Now) #Earnings #money
4 months ago 
Sab ko Bol
  - Reply
 - Share
rediff on the net© 2013 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Careers - Feedback - Sitemap   |   Terms of use